Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA

PHASE3RecruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

December 30, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Ticagrelor 90 MG

Efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever ischemic stroke followed by 90 mg bid for 3 months will be assessed through NIHSS, mRS, new ischemic stroke, and possible adverse effects.

DRUG

Cilostazol 100 MG

Efficacy and safety of 200 mg loading dose of cilostazol administered within 24 hours of first-ever ischemic stroke followed by 100 mg bid for 3 months will be assessed through NIHSS, mRS, new ischemic stroke, and possible adverse effects.

Trial Locations (1)

33155

RECRUITING

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER